Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy

go back to reference Attems J, Jellinger KA, Lintner F. Alzheimer’s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol. 2005;110:222–31.PubMedCrossRef Attems J, Jellinger KA, Lintner F. Alzheimer’s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol. 2005;110:222–31.PubMedCrossRef

go back to reference Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179:312–39.PubMedPubMedCentralCrossRef Long JM, Holtzman DM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell. 2019;179:312–39.PubMedPubMedCentralCrossRef

go back to reference Hanseeuw BJ, Betensky RA, Jacobs HIL, Schultz AP, Sepulcre J, Becker JA, Cosio DMO, Farrell M, Quiroz YT, Mormino EC, Buckley RF, Papp KV, Amariglio RA, Dewachter I, Ivanoiu A, Huijbers W, Hedden T, Marshall GA, Chhatwal JP, Rentz DM, Sperling RA, Johnson K. Association of Amyloid and Tau with cognition in preclinical alzheimer disease: a longitudinal study. JAMA Neurol. 2019;76:915–24.PubMedPubMedCentralCrossRef Hanseeuw BJ, Betensky RA, Jacobs HIL, Schultz AP, Sepulcre J, Becker JA, Cosio DMO, Farrell M, Quiroz YT, Mormino EC, Buckley RF, Papp KV, Amariglio RA, Dewachter I, Ivanoiu A, Huijbers W, Hedden T, Marshall GA, Chhatwal JP, Rentz DM, Sperling RA, Johnson K. Association of Amyloid and Tau with cognition in preclinical alzheimer disease: a longitudinal study. JAMA Neurol. 2019;76:915–24.PubMedPubMedCentralCrossRef

go back to reference Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ. Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways. Nat Rev Neurol. 2020;16:30–42.PubMedCrossRef Greenberg SM, Bacskai BJ, Hernandez-Guillamon M, Pruzin J, Sperling R, van Veluw SJ. Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways. Nat Rev Neurol. 2020;16:30–42.PubMedCrossRef

go back to reference Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ. Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology. 2002;58:1629–34.PubMedCrossRef Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ. Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology. 2002;58:1629–34.PubMedCrossRef

go back to reference Case NF, Charlton A, Zwiers A, Batool S, McCreary CR, Hogan DB, Ismail Z, Zerna C, Coutts SB, Frayne R, Goodyear B, Haffenden A, Smith EE. Cerebral amyloid angiopathy is associated with executive dysfunction and mild cognitive impairment. Stroke. 2016;47:2010–6.PubMedCrossRef Case NF, Charlton A, Zwiers A, Batool S, McCreary CR, Hogan DB, Ismail Z, Zerna C, Coutts SB, Frayne R, Goodyear B, Haffenden A, Smith EE. Cerebral amyloid angiopathy is associated with executive dysfunction and mild cognitive impairment. Stroke. 2016;47:2010–6.PubMedCrossRef

go back to reference Attems J, Jellinger K, Thal DR, Van Nostrand W. Review: Sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol. 2011;37:75–93.PubMedCrossRef Attems J, Jellinger K, Thal DR, Van Nostrand W. Review: Sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol. 2011;37:75–93.PubMedCrossRef

go back to reference Zipfel GJ, Han H, Ford AL, Lee JM. Cerebral amyloid angiopathy progressive disruption of the neurovascular unit. Stroke. 2009;40:S16–9.PubMedCrossRef Zipfel GJ, Han H, Ford AL, Lee JM. Cerebral amyloid angiopathy progressive disruption of the neurovascular unit. Stroke. 2009;40:S16–9.PubMedCrossRef

go back to reference Han BH, Zhou ML, Abousaleh F, Brendza RP, Dietrich HH, Koenigsknecht-Talboo J, Cirrito JR, Milner E, Holtzman DM, Zipfel GJ. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: Contribution of soluble and insoluble amyloid-β peptide, partial restoration via γ-secretase inhibition. J Neurosci. 2008;28:13542–50.PubMedPubMedCentralCrossRef Han BH, Zhou ML, Abousaleh F, Brendza RP, Dietrich HH, Koenigsknecht-Talboo J, Cirrito JR, Milner E, Holtzman DM, Zipfel GJ. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: Contribution of soluble and insoluble amyloid-β peptide, partial restoration via γ-secretase inhibition. J Neurosci. 2008;28:13542–50.PubMedPubMedCentralCrossRef

go back to reference Weller RO, Subash M, Preston SD, Mazanti I, Carare RO. Perivascular drainage of amyloid-β peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer’s disease. Brain Pathol. 2008;18:253–66.PubMedCrossRef Weller RO, Subash M, Preston SD, Mazanti I, Carare RO. Perivascular drainage of amyloid-β peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer’s disease. Brain Pathol. 2008;18:253–66.PubMedCrossRef

go back to reference Liao F, Yoon H, Kim J. Apolipoprotein E metabolism and functions in brain and its role in Alzheimerʼs disease. Curr Opin Lipidol. 2016;28:60–7.CrossRef Liao F, Yoon H, Kim J. Apolipoprotein E metabolism and functions in brain and its role in Alzheimerʼs disease. Curr Opin Lipidol. 2016;28:60–7.CrossRef

go back to reference Nelson P. T., Pious N. M., Jicha G. A., Wilcock D. M., Fardo D. W., Fardo S, Estus G, Rebeck G. William. APOE-ε2 and APOE ε4 correlate with increased amyloid accumulation in cerebral vasculature. J Neuropathol Exp Neurol. 2013;72:708–15.PubMedCrossRef Nelson P. T., Pious N. M., Jicha G. A., Wilcock D. M., Fardo D. W., Fardo S, Estus G, Rebeck G. William. APOE-ε2 and APOE ε4 correlate with increased amyloid accumulation in cerebral vasculature. J Neuropathol Exp Neurol. 2013;72:708–15.PubMedCrossRef

go back to reference Greenberg SM, Briggs ME, Hyman BT, Kokoris GJ, Takis C, Kanter DS, et al. Apolipoprotein E ε4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke. 1996;27:1333–7. Greenberg SM, Briggs ME, Hyman BT, Kokoris GJ, Takis C, Kanter DS, et al. Apolipoprotein E ε4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke. 1996;27:1333–7.

go back to reference Fryer JD, Simmons K, Parsadanian M, Bales KR, Paul SM, Sullivan PM, Holtzman DM. Human apolipoprotein E4 alters the amyloid-β 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. J Neurosci. 2005;25:2803–10.PubMedPubMedCentralCrossRef Fryer JD, Simmons K, Parsadanian M, Bales KR, Paul SM, Sullivan PM, Holtzman DM. Human apolipoprotein E4 alters the amyloid-β 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. J Neurosci. 2005;25:2803–10.PubMedPubMedCentralCrossRef

go back to reference Ringman JM, Sachs MC, Zhou Y, Monsell SE, Saver JL, Vinters HV. Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease. JAMA Neurol. 2014;71:878–83.PubMedPubMedCentralCrossRef Ringman JM, Sachs MC, Zhou Y, Monsell SE, Saver JL, Vinters HV. Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease. JAMA Neurol. 2014;71:878–83.PubMedPubMedCentralCrossRef

go back to reference Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90:1977–81.PubMedPubMedCentralCrossRef Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., Roses A. D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90:1977–81.PubMedPubMedCentralCrossRef

go back to reference Liu C-C, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9:106–18.PubMedPubMedCentralCrossRef Liu C-C, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9:106–18.PubMedPubMedCentralCrossRef

go back to reference Castellano J. M., Kim J., Stewart F. R., Jiang H., DeMattos R. B., Patterson B. W., Fagan A. M., Morris J. C., Mawuenyega K. G., Cruchaga C., Goate A. M., Bales K. R., Paul S. M., Bateman R. J., Holtzman D. M. Human apoE Isoforms Differentially Regulate Brain Amyloid-beta Peptide Clearance. Sci Transl Med. 2011;3:89ra57.PubMedPubMedCentralCrossRef Castellano J. M., Kim J., Stewart F. R., Jiang H., DeMattos R. B., Patterson B. W., Fagan A. M., Morris J. C., Mawuenyega K. G., Cruchaga C., Goate A. M., Bales K. R., Paul S. M., Bateman R. J., Holtzman D. M. Human apoE Isoforms Differentially Regulate Brain Amyloid-beta Peptide Clearance. Sci Transl Med. 2011;3:89ra57.PubMedPubMedCentralCrossRef

go back to reference Martens YA, Zhao N, Liu CC, Kanekiyo T, Yang AJ, Goate AM, Holtzman DM, Bu G. ApoE Cascade Hypothesis in the pathogenesis of Alzheimer’s disease and related dementias. Neuron. 2022;110:1304–17.PubMedCrossRef Martens YA, Zhao N, Liu CC, Kanekiyo T, Yang AJ, Goate AM, Holtzman DM, Bu G. ApoE Cascade Hypothesis in the pathogenesis of Alzheimer’s disease and related dementias. Neuron. 2022;110:1304–17.PubMedCrossRef

go back to reference Hawkes CA, Härtig W, Kacza J, Schliebs R, Weller RO, Nicoll JA, Carare RO. Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy. Acta Neuropathol. 2011;121:431–43.PubMedCrossRef Hawkes CA, Härtig W, Kacza J, Schliebs R, Weller RO, Nicoll JA, Carare RO. Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy. Acta Neuropathol. 2011;121:431–43.PubMedCrossRef

go back to reference Herzig M. C., Nostrand W. E. Van, Jucker M. Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol. 2006;16:40–54.PubMedPubMedCentralCrossRef Herzig M. C., Nostrand W. E. Van, Jucker M. Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol. 2006;16:40–54.PubMedPubMedCentralCrossRef

go back to reference Verbeek MM, Otte-Höller I, Veerhuis R, Ruiter DJ, De Waal RMW. Distribution of Aβ-associated proteins in cerebrovascular amyloid of Alzheimer’s disease. Acta Neuropathol. 1998;96:628–36.PubMedCrossRef Verbeek MM, Otte-Höller I, Veerhuis R, Ruiter DJ, De Waal RMW. Distribution of Aβ-associated proteins in cerebrovascular amyloid of Alzheimer’s disease. Acta Neuropathol. 1998;96:628–36.PubMedCrossRef

go back to reference Namba K., Tomonaga M, Kawasaki H, Otomo E, Ikeda. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 1991;541:163–6.PubMedCrossRef Namba K., Tomonaga M, Kawasaki H, Otomo E, Ikeda. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 1991;541:163–6.PubMedCrossRef

go back to reference Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett. 1992;135:235–8.PubMedCrossRef Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett. 1992;135:235–8.PubMedCrossRef

go back to reference Fryer J. D., Taylor J. W., DeMattos R. B., Bales K. R., Paul S. M., Parsadanian M., Holtzman D. M. Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice. J Neurosci. 2003;23:7889–96.PubMedPubMedCentralCrossRef Fryer J. D., Taylor J. W., DeMattos R. B., Bales K. R., Paul S. M., Parsadanian M., Holtzman D. M. Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice. J Neurosci. 2003;23:7889–96.PubMedPubMedCentralCrossRef

go back to reference Holtzman DM, Fagan AM, Mackey B, Tenkova T, Sartorius L, Paul SM, Bales K, Ashe KH, Irizarry MC, Hyman BT. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer’s disease model. Ann Neurol. 2000;47:739–47.PubMedCrossRef Holtzman DM, Fagan AM, Mackey B, Tenkova T, Sartorius L, Paul SM, Bales K, Ashe KH, Irizarry MC, Hyman BT. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer’s disease model. Ann Neurol. 2000;47:739–47.PubMedCrossRef

go back to reference Caselli RJ, Dueck AC, Locke DEC, Hoffman-Snyder CR, Woodruff BK, Rapcsak SZ, Reiman EM. Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriers. Neurology. 2011;76:1383–8.PubMedPubMedCentralCrossRef Caselli RJ, Dueck AC, Locke DEC, Hoffman-Snyder CR, Woodruff BK, Rapcsak SZ, Reiman EM. Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriers. Neurology. 2011;76:1383–8.PubMedPubMedCentralCrossRef

go back to reference Wierenga CE, Dev SI, Shin DD, Clark LR, Bangen KJ, Jak AJ, Rissman RA, Liu TT, Salmon DP, Bondi MW. Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition. J Cereb Blood Flow Metab. 2012;32:1589–99.PubMedPubMedCentralCrossRef Wierenga CE, Dev SI, Shin DD, Clark LR, Bangen KJ, Jak AJ, Rissman RA, Liu TT, Salmon DP, Bondi MW. Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition. J Cereb Blood Flow Metab. 2012;32:1589–99.PubMedPubMedCentralCrossRef

go back to reference Kisler K, Nelson AR, Montagne A, Zlokovic BV. Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci. 2017;18:419–34.PubMedPubMedCentralCrossRef Kisler K, Nelson AR, Montagne A, Zlokovic BV. Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci. 2017;18:419–34.PubMedPubMedCentralCrossRef

go back to reference Tai LM, Thomas R, Marottoli FM, Koster KP, Kanekiyo T, Morris AWJ, Bu G. The role of APOE in cerebrovascular dysfunction. Acta Neuropathol. 2016;131:709–23.PubMedPubMedCentralCrossRef Tai LM, Thomas R, Marottoli FM, Koster KP, Kanekiyo T, Morris AWJ, Bu G. The role of APOE in cerebrovascular dysfunction. Acta Neuropathol. 2016;131:709–23.PubMedPubMedCentralCrossRef

go back to reference Montagne A., Nation D. A., Sagare A. P., Barisano G., Sweeney M. D., Chakhoyan A., Pachicano M., Joe E., Nelson A. R., D’Orazio L. M., Buennagel D. P., Harrington M. G., Benzinger T. L. S., Fagan A. M., Ringman J. M., Schneider L. S., Morris J. C., Reiman E. M., Caselli R. J., Chui H. C., TCW J., Chen Y., Pa J., Conti P. S., Law M., Toga A. W., Zlokovic B. V. APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline. Nature. 2020;581:71–6.PubMedPubMedCentralCrossRef Montagne A., Nation D. A., Sagare A. P., Barisano G., Sweeney M. D., Chakhoyan A., Pachicano M., Joe E., Nelson A. R., D’Orazio L. M., Buennagel D. P., Harrington M. G., Benzinger T. L. S., Fagan A. M., Ringman J. M., Schneider L. S., Morris J. C., Reiman E. M., Caselli R. J., Chui H. C., TCW J., Chen Y., Pa J., Conti P. S., Law M., Toga A. W., Zlokovic B. V. APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline. Nature. 2020;581:71–6.PubMedPubMedCentralCrossRef

go back to reference Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM, Betsholtz C, Armulik A, Sallstrom J, Berk BC, Zlokovic BV. Apolipoprotein e controls cerebrovascular integrity via cyclophilin A. Nature. 2012;485:512–6.PubMedPubMedCentralCrossRef Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM, Betsholtz C, Armulik A, Sallstrom J, Berk BC, Zlokovic BV. Apolipoprotein e controls cerebrovascular integrity via cyclophilin A. Nature. 2012;485:512–6.PubMedPubMedCentralCrossRef

go back to reference Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, Itzkovitz S, Colonna M, Schwartz M, Amit I. A unique microglia type associated with restricting development of alzheimer’s disease. Cell. 2017;169:1276-1290.e17.PubMedCrossRef Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, Itzkovitz S, Colonna M, Schwartz M, Amit I. A unique microglia type associated with restricting development of alzheimer’s disease. Cell. 2017;169:1276-1290.e17.PubMedCrossRef

go back to reference Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L, O’Loughlin E, Xu Y, Fanek Z, Greco DJ, Smith ST, Tweet G, Humulock Z, Zrzavy T, Conde-Sanroman P, Gacias M, Weng Z, Chen H, Tjon E, Mazaheri F, Hartmann K, Madi A, Ulrich JD, Glatzel M, Worthmann A, Heeren J, Budnik B, Lemere C, Ikezu T, Heppner FL, Litvak V, Holtzman DM, Lassmann H, Weiner HL, Ochando J, Haass C, Butovsky O. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47:566-581.e9.PubMedPubMedCentralCrossRef Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L, O’Loughlin E, Xu Y, Fanek Z, Greco DJ, Smith ST, Tweet G, Humulock Z, Zrzavy T, Conde-Sanroman P, Gacias M, Weng Z, Chen H, Tjon E, Mazaheri F, Hartmann K, Madi A, Ulrich JD, Glatzel M, Worthmann A, Heeren J, Budnik B, Lemere C, Ikezu T, Heppner FL, Litvak V, Holtzman DM, Lassmann H, Weiner HL, Ochando J, Haass C, Butovsky O. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47:566-581.e9.PubMedPubMedCentralCrossRef

go back to reference Mahley RW, Huang Y. Apolipoprotein E Sets the stage: response to injury triggers neuropathology. Neuron. 2012;76:871–85.PubMedPubMedCentralCrossRef Mahley RW, Huang Y. Apolipoprotein E Sets the stage: response to injury triggers neuropathology. Neuron. 2012;76:871–85.PubMedPubMedCentralCrossRef

go back to reference Yamazaki Y, Shinohara M, Yamazaki A, Ren Y, Asmann YW, Kanekiyo T, Bu G, Clinic M, Clinic M. ApoE in brain pericytes regulates endothelial function in an isoform-dependent manner by modulating basement membrane components. Arter Thromb Vasc Biol. 2021;40:128–44.CrossRef Yamazaki Y, Shinohara M, Yamazaki A, Ren Y, Asmann YW, Kanekiyo T, Bu G, Clinic M, Clinic M. ApoE in brain pericytes regulates endothelial function in an isoform-dependent manner by modulating basement membrane components. Arter Thromb Vasc Biol. 2021;40:128–44.CrossRef

go back to reference Blanchard JW, Bula M, Davila-Velderrain J, Akay LA, Zhu L, Frank A, Victor MB, Bonner JM, Mathys H, Lin YT, Ko T, Bennett DA, Cam HP, Kellis M, Tsai LH. Reconstruction of the human blood–brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes. Nat Med. 2020;26:952–63.PubMedPubMedCentralCrossRef Blanchard JW, Bula M, Davila-Velderrain J, Akay LA, Zhu L, Frank A, Victor MB, Bonner JM, Mathys H, Lin YT, Ko T, Bennett DA, Cam HP, Kellis M, Tsai LH. Reconstruction of the human blood–brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes. Nat Med. 2020;26:952–63.PubMedPubMedCentralCrossRef

go back to reference Lin Y-T, Seo J, Gao F, Feldman HM, Wen H-L, Penney J, Cam HP, Gjoneska E, Raja WK, Cheng J, Rueda R, Kritskiy O, Abdurrob F, Peng Z, Milo B, Yu CJ, Elmsaouri S, Dey D, Ko T, Yankner BA, Tsai L-H. APOE4 Causes widespread molecular and cellular alterations associated with Alzheimer’s disease phenotypes in human ipsc-derived brain cell types. Neuron. 2018;98:1141-1154.e7.PubMedPubMedCentralCrossRef Lin Y-T, Seo J, Gao F, Feldman HM, Wen H-L, Penney J, Cam HP, Gjoneska E, Raja WK, Cheng J, Rueda R, Kritskiy O, Abdurrob F, Peng Z, Milo B, Yu CJ, Elmsaouri S, Dey D, Ko T, Yankner BA, Tsai L-H. APOE4 Causes widespread molecular and cellular alterations associated with Alzheimer’s disease phenotypes in human ipsc-derived brain cell types. Neuron. 2018;98:1141-1154.e7.PubMedPubMedCentralCrossRef

go back to reference Rawat V, Wang S, Sima J, Bar R, Liraz O, Gundimeda U, Parekh T, Chan J, Johansson JO, Tang C, Chui HC, Harrington MG, Michaelson DM, Yassine HN. ApoE4 Alters ABCA1 membrane trafficking in astrocytes. J Neurosci. 2019;39:9611–22.PubMedPubMedCentralCrossRef Rawat V, Wang S, Sima J, Bar R, Liraz O, Gundimeda U, Parekh T, Chan J, Johansson JO, Tang C, Chui HC, Harrington MG, Michaelson DM, Yassine HN. ApoE4 Alters ABCA1 membrane trafficking in astrocytes. J Neurosci. 2019;39:9611–22.PubMedPubMedCentralCrossRef

go back to reference T.C.W. J, Qian L, Pipalia NH, Chao MJ, Liang SA, Shi Y, et al. Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. Cell. 2022;185:2213–33. T.C.W. J, Qian L, Pipalia NH, Chao MJ, Liang SA, Shi Y, et al. Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. Cell. 2022;185:2213–33.

go back to reference Habib N, Mccabe C, Medina S, Varshavsky M, Kitsberg D, Dvir-szternfeld R, Green G, Dionne D, Nguyen L, Marshall JL, Chen F, Zhang F, Kaplan T, Regev A, Schwartz M. Disease-associated astrocytes in Alzheimer’s disease and aging. Nat Neurosci. 2020;23:701–6.PubMedPubMedCentralCrossRef Habib N, Mccabe C, Medina S, Varshavsky M, Kitsberg D, Dvir-szternfeld R, Green G, Dionne D, Nguyen L, Marshall JL, Chen F, Zhang F, Kaplan T, Regev A, Schwartz M. Disease-associated astrocytes in Alzheimer’s disease and aging. Nat Neurosci. 2020;23:701–6.PubMedPubMedCentralCrossRef

go back to reference Taylor X, Cisternas P, You Y, You Y, Xiang S, Marambio Y, Zhang J, Vidal R, Lasagna-Reeves CA. A1 reactive astrocytes and a loss of TREM2 are associated with an early stage of pathology in a mouse model of cerebral amyloid angiopathy. J Neuroinflammation. 2020;17:223.PubMedPubMedCentralCrossRef Taylor X, Cisternas P, You Y, You Y, Xiang S, Marambio Y, Zhang J, Vidal R, Lasagna-Reeves CA. A1 reactive astrocytes and a loss of TREM2 are associated with an early stage of pathology in a mouse model of cerebral amyloid angiopathy. J Neuroinflammation. 2020;17:223.PubMedPubMedCentralCrossRef

go back to reference Sadick J. S., O’Dea M. R., Hasel P., Dykstra T., Faustin A., Liddelow S. A. Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer’s disease. Neuron. 2022;110:1788-1805.e10.PubMedCrossRef Sadick J. S., O’Dea M. R., Hasel P., Dykstra T., Faustin A., Liddelow S. A. Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer’s disease. Neuron. 2022;110:1788-1805.e10.PubMedCrossRef

go back to reference Escartin C, Galea E, Lakatos A, O’Callaghan JP, Petzold GC, Serrano-Pozo ACS, Volterra A, Carmignoto G, Agarwal A, Allen NJ, Araque A, Barbeito L, Barzilai A, Bergles DE, Bonvento G, Butt AM, Chen W-T, Cohen-Salmon M, Cunningham C, Deneen B, De Strooper B, Díaz-Castro B, Farina C, Freeman M, Gallo V, Goldman JE, Goldman SA, Götz M, Gutiérrez A, Haydon PG, Heiland DH, Hol EM, Holt MG, Iino M, Kastanenka KV, Kettenmann H, Khakh BS, Koizumi S, Lee CJ, Liddelow SA, MacVicar BA, Magistretti P, Messing A, Mishra A, Molofsky AV, Murai KK, Norris CM, Okada S, Oliet SHR, Oliveira JF, Panatier A, Parpura V, Pekna M, Pekny M, Pellerin L, Perea G, Pérez-Nievas BG, Pfrieger FW, Poskanzer KE, Quintana FJ, Ransohoff RM, Riquelme-Perez M, Robel S, Rose CR, Rothstein JD, Rouach N, Rowitch DH, Semyanov A, Sirko S, Sontheimer H, Swanson RA, Vitorica J, Wanner I-B, Wood LB, Wu J, Zheng B, Zimmer ER, Zorec R, Sofroniew MV, Verkhratsky A. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24:312–25.PubMedPubMedCentralCrossRef Escartin C, Galea E, Lakatos A, O’Callaghan JP, Petzold GC, Serrano-Pozo ACS, Volterra A, Carmignoto G, Agarwal A, Allen NJ, Araque A, Barbeito L, Barzilai A, Bergles DE, Bonvento G, Butt AM, Chen W-T, Cohen-Salmon M, Cunningham C, Deneen B, De Strooper B, Díaz-Castro B, Farina C, Freeman M, Gallo V, Goldman JE, Goldman SA, Götz M, Gutiérrez A, Haydon PG, Heiland DH, Hol EM, Holt MG, Iino M, Kastanenka KV, Kettenmann H, Khakh BS, Koizumi S, Lee CJ, Liddelow SA, MacVicar BA, Magistretti P, Messing A, Mishra A, Molofsky AV, Murai KK, Norris CM, Okada S, Oliet SHR, Oliveira JF, Panatier A, Parpura V, Pekna M, Pekny M, Pellerin L, Perea G, Pérez-Nievas BG, Pfrieger FW, Poskanzer KE, Quintana FJ, Ransohoff RM, Riquelme-Perez M, Robel S, Rose CR, Rothstein JD, Rouach N, Rowitch DH, Semyanov A, Sirko S, Sontheimer H, Swanson RA, Vitorica J, Wanner I-B, Wood LB, Wu J, Zheng B, Zimmer ER, Zorec R, Sofroniew MV, Verkhratsky A. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24:312–25.PubMedPubMedCentralCrossRef

go back to reference Eran S, Ronit PK. APOE4 expression is associated with impaired autophagy and mitophagy in astrocytes. Neural Regen Res. 2022;17:777–8.PubMedCrossRef Eran S, Ronit PK. APOE4 expression is associated with impaired autophagy and mitophagy in astrocytes. Neural Regen Res. 2022;17:777–8.PubMedCrossRef

go back to reference Wilcock DM, Vitek MP, Colton CA. Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer’s disease. Neuroscience. 2009;159:1055–69.PubMedCrossRef Wilcock DM, Vitek MP, Colton CA. Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer’s disease. Neuroscience. 2009;159:1055–69.PubMedCrossRef

go back to reference Zheng J. yu, Sun J., Ji C. mei, Shen L., Chen Z. jun, Xie P., Sun Y. zhao, Yu R. tong. Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer’s disease (APP/PS1) mice by inhibiting TGF-β/Smad2/STAT3 signaling. Neurobiol Aging. 2017;54:112–32.PubMedCrossRef Zheng J. yu, Sun J., Ji C. mei, Shen L., Chen Z. jun, Xie P., Sun Y. zhao, Yu R. tong. Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer’s disease (APP/PS1) mice by inhibiting TGF-β/Smad2/STAT3 signaling. Neurobiol Aging. 2017;54:112–32.PubMedCrossRef

go back to reference Mahan TE, Wang C, Bao X, Choudhury A, Ulrich JD, Holtzman DM. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis. Mol Neurodegener. 2022;17:1–20.CrossRef Mahan TE, Wang C, Bao X, Choudhury A, Ulrich JD, Holtzman DM. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis. Mol Neurodegener. 2022;17:1–20.CrossRef

go back to reference Wang C, Xiong M, Gratuze M, Bao X, Shi Y, Andhey PS, Manis M, Schroeder C, Yin Z, Madore C, Butovsky O, Artyomov M, Ulrich JD, Holtzman DM. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron. 2021;109:1657-1674.e7.PubMedPubMedCentralCrossRef Wang C, Xiong M, Gratuze M, Bao X, Shi Y, Andhey PS, Manis M, Schroeder C, Yin Z, Madore C, Butovsky O, Artyomov M, Ulrich JD, Holtzman DM. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron. 2021;109:1657-1674.e7.PubMedPubMedCentralCrossRef

go back to reference Jackson RJ, Meltzer JC, Nguyen H, Commins C, Bennett RE, Hudry E, Hyman BT. APOE4 derived from astrocytes leads to blood–brain barrier impairment. Brain. 2022;145:3582–93.PubMedCrossRef Jackson RJ, Meltzer JC, Nguyen H, Commins C, Bennett RE, Hudry E, Hyman BT. APOE4 derived from astrocytes leads to blood–brain barrier impairment. Brain. 2022;145:3582–93.PubMedCrossRef

go back to reference Srinivasan R, Lu T, Chai H, Xu J, Huang BS, Golshani P, Coppola G, Khakh BS. New transgenic mouse lines for selectively targeting astrocytes and studying calcium signals in astrocyte processes In Situ and In Vivo neuroresource new transgenic mouse lines for selectively targeting astrocytes and studying calcium signals in astrocyte. Neuron. 2016;92:1181–95.PubMedPubMedCentralCrossRef Srinivasan R, Lu T, Chai H, Xu J, Huang BS, Golshani P, Coppola G, Khakh BS. New transgenic mouse lines for selectively targeting astrocytes and studying calcium signals in astrocyte processes In Situ and In Vivo neuroresource new transgenic mouse lines for selectively targeting astrocytes and studying calcium signals in astrocyte. Neuron. 2016;92:1181–95.PubMedPubMedCentralCrossRef

go back to reference Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R. Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: Potential factors in amyloid plaque formation. J Neurosci. 2006;26:10129–40.PubMedPubMedCentralCrossRef Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R. Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: Potential factors in amyloid plaque formation. J Neurosci. 2006;26:10129–40.PubMedPubMedCentralCrossRef

go back to reference Huynh TPV, Wang C, Tran AC, Tabor GT, Mahan TE, Francis CM, et al. Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model. Mol Neurodegener. 2019;1–23. Huynh TPV, Wang C, Tran AC, Tabor GT, Mahan TE, Francis CM, et al. Lack of hepatic apoE does not influence early Aβ deposition: observations from a new APOE knock-in model. Mol Neurodegener. 2019;1–23.

go back to reference Xiong M, Jiang H, Serrano JR, Gonzales ER, Wang C, Gratuze M, Hoyle R, Bien-ly N, Silverman AP, Sullivan PM, Watts RJ, Ulrich JD, Zipfel GJ, Holtzman DM. APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function. Sci Transl Med. 2021;13:1–13.CrossRef Xiong M, Jiang H, Serrano JR, Gonzales ER, Wang C, Gratuze M, Hoyle R, Bien-ly N, Silverman AP, Sullivan PM, Watts RJ, Ulrich JD, Zipfel GJ, Holtzman DM. APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function. Sci Transl Med. 2021;13:1–13.CrossRef

go back to reference Liao F, Li A, Xiong M, Bien-Ly N, Jiang H, Zhang Y, Finn MB, Hoyle R, Keyser J, Lefton KB, Robinson GO, Serrano JR, Silverman AP, Guo JL, Getz J, Henne K, Leyns CEG, Gallardo G, Ulrich JD, Sullivan PM, Lerner EP, Hudry E, Sweeney ZK, Dennis MS, Hyman BT, Watts RJ, Holtzman DM. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. J Clin Invest. 2018;128:2144–55.PubMedPubMedCentralCrossRef Liao F, Li A, Xiong M, Bien-Ly N, Jiang H, Zhang Y, Finn MB, Hoyle R, Keyser J, Lefton KB, Robinson GO, Serrano JR, Silverman AP, Guo JL, Getz J, Henne K, Leyns CEG, Gallardo G, Ulrich JD, Sullivan PM, Lerner EP, Hudry E, Sweeney ZK, Dennis MS, Hyman BT, Watts RJ, Holtzman DM. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. J Clin Invest. 2018;128:2144–55.PubMedPubMedCentralCrossRef

go back to reference McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu D, et al. Aβ42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron. 2005;47:191–9. McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu D, et al. Aβ42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron. 2005;47:191–9.

go back to reference Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, Nuscher B, Xiong M, Ghasemigharagoz A, Katzmarski N, Krasemann S, Lichtenthaler SF, Müller SA, Colombo A, Monasor LS, Tahirovic S, Herms J, Willem M, Pettkus N, Butovsky O, Bartenstein P, Edbauer D, Rominger A, Ertürk A, Grathwohl SA, Neher JJ, Holtzman DM, Meyer-Luehmann M, Haass C. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci. 2019;22:191–204.PubMedPubMedCentralCrossRef Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, Nuscher B, Xiong M, Ghasemigharagoz A, Katzmarski N, Krasemann S, Lichtenthaler SF, Müller SA, Colombo A, Monasor LS, Tahirovic S, Herms J, Willem M, Pettkus N, Butovsky O, Bartenstein P, Edbauer D, Rominger A, Ertürk A, Grathwohl SA, Neher JJ, Holtzman DM, Meyer-Luehmann M, Haass C. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci. 2019;22:191–204.PubMedPubMedCentralCrossRef

go back to reference Jiwaji Z, Tiwari SS, Avilés-Reyes RX, Hooley M, Hampton D, Torvell M, Johnson DA, McQueen J, Baxter P, Sabari-Sankar K, Qiu J, He X, Fowler J, Febery J, Gregory J, Rose J, Tulloch J, Loan J, Story D, McDade K, Smith AM, Greer P, Ball M, Kind PC, Matthews PM, Smith C, Dando O, Spires-Jones TL, Johnson JA, Chandran S, Hardingham GE. Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology. Nat Commun. 2022;13:1–23.CrossRef Jiwaji Z, Tiwari SS, Avilés-Reyes RX, Hooley M, Hampton D, Torvell M, Johnson DA, McQueen J, Baxter P, Sabari-Sankar K, Qiu J, He X, Fowler J, Febery J, Gregory J, Rose J, Tulloch J, Loan J, Story D, McDade K, Smith AM, Greer P, Ball M, Kind PC, Matthews PM, Smith C, Dando O, Spires-Jones TL, Johnson JA, Chandran S, Hardingham GE. Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology. Nat Commun. 2022;13:1–23.CrossRef

go back to reference Su H, Cummings BJ, Cotman CW. Identification and distribution of axonal dystrophic neurites in Alzheimer ’ s disease. Brain Res. 1993;625:228–37.PubMedCrossRef Su H, Cummings BJ, Cotman CW. Identification and distribution of axonal dystrophic neurites in Alzheimer ’ s disease. Brain Res. 1993;625:228–37.PubMedCrossRef

go back to reference Oshima K, Uchikado H, Dickson DW. Perivascular neuritic dystrophy associated with cerebral amyloid angiopathy in Alzheimer’s Disease. Int J Clin Exp Pathol. 2008;1:403–8.PubMedPubMedCentral Oshima K, Uchikado H, Dickson DW. Perivascular neuritic dystrophy associated with cerebral amyloid angiopathy in Alzheimer’s Disease. Int J Clin Exp Pathol. 2008;1:403–8.PubMedPubMedCentral

go back to reference Ulrich J. D., Ulland T. K., Mahan T. E., Nyström S., Peter Nilsson K., Song W. M., Zhou Y., Reinartz M., Choi S., Jiang H., Stewart F. R., Anderson E., Wang Y., Colonna M., Holtzman D. M. ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med. 2018;215:1047–58.PubMedPubMedCentralCrossRef Ulrich J. D., Ulland T. K., Mahan T. E., Nyström S., Peter Nilsson K., Song W. M., Zhou Y., Reinartz M., Choi S., Jiang H., Stewart F. R., Anderson E., Wang Y., Colonna M., Holtzman D. M. ApoE facilitates the microglial response to amyloid plaque pathology. J Exp Med. 2018;215:1047–58.PubMedPubMedCentralCrossRef

go back to reference Raulin A, Kraft L, Al-hilaly YK, Xue W, Mcgeehan JE, Atack JR, Serpell L. The molecular basis for apolipoprotein e4 as the major risk factor for late-onset Alzheimer ’ s Disease. J Mol Biol. 2019;431:2248–65.PubMedPubMedCentralCrossRef Raulin A, Kraft L, Al-hilaly YK, Xue W, Mcgeehan JE, Atack JR, Serpell L. The molecular basis for apolipoprotein e4 as the major risk factor for late-onset Alzheimer ’ s Disease. J Mol Biol. 2019;431:2248–65.PubMedPubMedCentralCrossRef

go back to reference Chen Y, Strickland MR, Soranno A, Holtzman DM. Apolipoprotein E: structural insights and links to alzheimer disease pathogenesis. Neuron. 2021;109:205–21.PubMedCrossRef Chen Y, Strickland MR, Soranno A, Holtzman DM. Apolipoprotein E: structural insights and links to alzheimer disease pathogenesis. Neuron. 2021;109:205–21.PubMedCrossRef

go back to reference Garai K, Verghese PB, Baban B, Holtzman DM, Frieden C. The binding of apolipoprotein e to oligomers and fibrils of amyloid-β alters the kinetics of amyloid aggregation. Biochemistry. 2014;53:6323–31.PubMedCrossRef Garai K, Verghese PB, Baban B, Holtzman DM, Frieden C. The binding of apolipoprotein e to oligomers and fibrils of amyloid-β alters the kinetics of amyloid aggregation. Biochemistry. 2014;53:6323–31.PubMedCrossRef

go back to reference Golabek AA, Soto C, Vogel T, Wisniewski T. The Interaction between Apolipoprotein E and Alzheimer’s Amyloid β-Peptide Is Dependent on β-Peptide Conformatio. J Biol Chem. 1996;271:10602–6.PubMedCrossRef Golabek AA, Soto C, Vogel T, Wisniewski T. The Interaction between Apolipoprotein E and Alzheimer’s Amyloid β-Peptide Is Dependent on β-Peptide Conformatio. J Biol Chem. 1996;271:10602–6.PubMedCrossRef

go back to reference Wisniewski T, Castano EM, Golabek A, Vogel T. Acceleration of Alzheimer’s fibril formation by apolipoprotein E in vitro. Am J Pathol. 1994;145:1030–5.PubMedPubMedCentral Wisniewski T, Castano EM, Golabek A, Vogel T. Acceleration of Alzheimer’s fibril formation by apolipoprotein E in vitro. Am J Pathol. 1994;145:1030–5.PubMedPubMedCentral

go back to reference Castano EM, Prelli F, Wisniewski T, Golabek A, Kumar RA, Soto C, Frangione B. Fibrillogenesis in Alzheimer’s disease of amyloid beta peptides and apolipoprotein E. Biochem J. 1995;306:599–604.PubMedPubMedCentralCrossRef Castano EM, Prelli F, Wisniewski T, Golabek A, Kumar RA, Soto C, Frangione B. Fibrillogenesis in Alzheimer’s disease of amyloid beta peptides and apolipoprotein E. Biochem J. 1995;306:599–604.PubMedPubMedCentralCrossRef

go back to reference DeMattos RB, Cirrito JR, Parsadanian M, May PC, Dell MAO, Taylor JW, Harmony JAK, Aronow BJ, Bales KR, Paul SM, Holtzman DM. ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron. 2004;41:193–202.PubMedCrossRef DeMattos RB, Cirrito JR, Parsadanian M, May PC, Dell MAO, Taylor JW, Harmony JAK, Aronow BJ, Bales KR, Paul SM, Holtzman DM. ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron. 2004;41:193–202.PubMedCrossRef

go back to reference Deane R, Bell R, Sagare A, Zlokovic B. Clearance of Amyloid-β peptide across the blood-brain barrier: implication for therapies in Alzheimers Disease. CNS Neurol Disord - Drug Targets. 2009;8:16–30.PubMedPubMedCentralCrossRef Deane R, Bell R, Sagare A, Zlokovic B. Clearance of Amyloid-β peptide across the blood-brain barrier: implication for therapies in Alzheimers Disease. CNS Neurol Disord - Drug Targets. 2009;8:16–30.PubMedPubMedCentralCrossRef

go back to reference Paresce D, Ghosh R, Maxfield F. Microglial cells internalize aggregates of the Alzheimer’s Disease Amyloid β-Protein via a scavenger receptor. Neuron. 1996;17:553–65.PubMedCrossRef Paresce D, Ghosh R, Maxfield F. Microglial cells internalize aggregates of the Alzheimer’s Disease Amyloid β-Protein via a scavenger receptor. Neuron. 1996;17:553–65.PubMedCrossRef

go back to reference Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med. 2012;4:147ra111–147ra111. Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med. 2012;4:147ra111–147ra111.

go back to reference Vanlandewijck M, He L, Mäe MA, Andrae J, Ando K, Del Gaudio F, Nahar K, Lebouvier T, Laviña B, Gouveia L, Sun Y, Raschperger E, Räsänen M, Zarb Y, Mochizuki N, Keller A, Lendahl U, Betsholtz C. A molecular atlas of cell types and zonation in the brain vasculature. Nature. 2018;554:475–80.PubMedCrossRef Vanlandewijck M, He L, Mäe MA, Andrae J, Ando K, Del Gaudio F, Nahar K, Lebouvier T, Laviña B, Gouveia L, Sun Y, Raschperger E, Räsänen M, Zarb Y, Mochizuki N, Keller A, Lendahl U, Betsholtz C. A molecular atlas of cell types and zonation in the brain vasculature. Nature. 2018;554:475–80.PubMedCrossRef

go back to reference Huang Y, Happonen KE, Burrola PG, O’Connor C, Hah N, Huang L, Nimmerjahn A, Lemke G. Microglia use TAM receptors to detect and engulf amyloid β plaques. Nat Immunol. 2021;22:586–94.PubMedPubMedCentralCrossRef Huang Y, Happonen KE, Burrola PG, O’Connor C, Hah N, Huang L, Nimmerjahn A, Lemke G. Microglia use TAM receptors to detect and engulf amyloid β plaques. Nat Immunol. 2021;22:586–94.PubMedPubMedCentralCrossRef

go back to reference Spangenberg EE, Lee RJ, Najafi AR, Rice RA, Elmore MRP, Blurton-Jones M, West BL, Green KN. Eliminating microglia in Alzheimer’s mice prevents neuronal loss without modulating amyloid-β pathology. Brain. 2016;139:1265–81.PubMedPubMedCentralCrossRef Spangenberg EE, Lee RJ, Najafi AR, Rice RA, Elmore MRP, Blurton-Jones M, West BL, Green KN. Eliminating microglia in Alzheimer’s mice prevents neuronal loss without modulating amyloid-β pathology. Brain. 2016;139:1265–81.PubMedPubMedCentralCrossRef

go back to reference Shabestari SK, Morabito S, Danhash EP, Mcquade A, Sanchez JR, Miyoshi E, Chadarevian JP, Claes C, Coburn MA, Hasselmann J, Hidalgo J, Tran KN, Martini AC, Rothermich WC, Pascual J, Head E, Hume DA, Pridans C, Davtyan H, Swarup V, Blurton-Jones M. Absence of microglia promotes diverse pathologies and early lethality in Alzheimer’s disease mice. Cell Rep. 2022;39: 110961.PubMedCentralCrossRef Shabestari SK, Morabito S, Danhash EP, Mcquade A, Sanchez JR, Miyoshi E, Chadarevian JP, Claes C, Coburn MA, Hasselmann J, Hidalgo J, Tran KN, Martini AC, Rothermich WC, Pascual J, Head E, Hume DA, Pridans C, Davtyan H, Swarup V, Blurton-Jones M. Absence of microglia promotes diverse pathologies and early lethality in Alzheimer’s disease mice. Cell Rep. 2022;39: 110961.PubMedCentralCrossRef

go back to reference Shi Y, Manis M, Long J, Wang K, Sullivan PM, Serrano JR, Hoyle R, Holtzman DM. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J Exp Med. 2019;216:2546–61.PubMedPubMedCentralCrossRef Shi Y, Manis M, Long J, Wang K, Sullivan PM, Serrano JR, Hoyle R, Holtzman DM. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J Exp Med. 2019;216:2546–61.PubMedPubMedCentralCrossRef

go back to reference Camacho J, Moliné T, Bonaterra-Pastra A, Cajal SRY, Martínez-Sáez E, Hernández-Guillamon M. Brain ApoA-I, ApoJ and ApoE immunodetection in cerebral amyloid angiopathy. Front Neurol. 2019;10:1–12.CrossRef Camacho J, Moliné T, Bonaterra-Pastra A, Cajal SRY, Martínez-Sáez E, Hernández-Guillamon M. Brain ApoA-I, ApoJ and ApoE immunodetection in cerebral amyloid angiopathy. Front Neurol. 2019;10:1–12.CrossRef

go back to reference Wojtas AM, Kang SS, Olley BM, Gatherer M, Shinohara M, Lozano PA, Liu CC, Kurti A, Baker KE, Dickson DW, Yue M, Petrucelli L, Bu G, Carare RO, Fryer JD. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways. Proc Natl Acad Sci U S A. 2017;114:E6962–71.PubMedPubMedCentralCrossRef Wojtas AM, Kang SS, Olley BM, Gatherer M, Shinohara M, Lozano PA, Liu CC, Kurti A, Baker KE, Dickson DW, Yue M, Petrucelli L, Bu G, Carare RO, Fryer JD. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways. Proc Natl Acad Sci U S A. 2017;114:E6962–71.PubMedPubMedCentralCrossRef

go back to reference Abbott NJ, Rönnbäck L, Hansson E. Astrocyte – endothelial interactions at the blood – brain barrier. Nat Rev Neurosci. 2006;7:41–53.PubMedCrossRef Abbott NJ, Rönnbäck L, Hansson E. Astrocyte – endothelial interactions at the blood – brain barrier. Nat Rev Neurosci. 2006;7:41–53.PubMedCrossRef

go back to reference Sofroniew MV. Astrocyte barriers to neurotoxic inflammation. Nat Rev Neurosci. 2015;16:249–63.PubMedPubMedCentralCrossRef Sofroniew MV. Astrocyte barriers to neurotoxic inflammation. Nat Rev Neurosci. 2015;16:249–63.PubMedPubMedCentralCrossRef

go back to reference Hasel P, Rose IVL, Sadick JS, Kim RD, Liddelow SA. Neuroinflammatory astrocyte subtypes in the mouse brain. Nat Neurosci. 2021;24:1475–87.PubMedCrossRef Hasel P, Rose IVL, Sadick JS, Kim RD, Liddelow SA. Neuroinflammatory astrocyte subtypes in the mouse brain. Nat Neurosci. 2021;24:1475–87.PubMedCrossRef

go back to reference Moftakhar P, Lynch MD, Pomakian JL, Vinters HV. Aquaporin Expression in the brains of patients with or without cerebral amyloid angiopathy. J Neuropathol Exp Neurol. 2010;69:1201–9.PubMedCrossRef Moftakhar P, Lynch MD, Pomakian JL, Vinters HV. Aquaporin Expression in the brains of patients with or without cerebral amyloid angiopathy. J Neuropathol Exp Neurol. 2010;69:1201–9.PubMedCrossRef

go back to reference Gratuze M, Jiang H, Wang C, Xiong M, Bao X, Holtzman D. APOE Antibody inhibits Aβ-Associated Tau seeding and spreading in a mouse model. Ann Neurol. 2022;91:847–52.PubMedCrossRef Gratuze M, Jiang H, Wang C, Xiong M, Bao X, Holtzman D. APOE Antibody inhibits Aβ-Associated Tau seeding and spreading in a mouse model. Ann Neurol. 2022;91:847–52.PubMedCrossRef

go back to reference Huynh TPV, Liao F, Francis CM, Robinson GO, Serrano JR, Jiang H, Roh J, Finn MB, Sullivan PM, Esparza TJ, Stewart FR, Mahan TE, Ulrich JD, Cole T, Holtzman DM. Age-Dependent effects of apoE reduction using antisense oligonucleotides in a model of β-amyloidosis. Neuron. 2017;96:1013-1023.e4.PubMedPubMedCentralCrossRef Huynh TPV, Liao F, Francis CM, Robinson GO, Serrano JR, Jiang H, Roh J, Finn MB, Sullivan PM, Esparza TJ, Stewart FR, Mahan TE, Ulrich JD, Cole T, Holtzman DM. Age-Dependent effects of apoE reduction using antisense oligonucleotides in a model of β-amyloidosis. Neuron. 2017;96:1013-1023.e4.PubMedPubMedCentralCrossRef

go back to reference Vitek MP, Christensen DJ, Wilcock D, Davis J, Van Nostrand WE, Li FQ, Colton CA. APOE-mimetic peptides reduce behavioral deficits, plaques and tangles in Alzheimer’s disease transgenics. Neurodegener Dis. 2012;10:122–6.PubMedPubMedCentralCrossRef Vitek MP, Christensen DJ, Wilcock D, Davis J, Van Nostrand WE, Li FQ, Colton CA. APOE-mimetic peptides reduce behavioral deficits, plaques and tangles in Alzheimer’s disease transgenics. Neurodegener Dis. 2012;10:122–6.PubMedPubMedCentralCrossRef

go back to reference Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15:501–18.PubMedPubMedCentralCrossRef Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15:501–18.PubMedPubMedCentralCrossRef

go back to reference Montagne A, Nikolakopoulou AM, Huuskonen MT, Sagare AP, Lawson EJ, Lazic D, Rege SV, Grond A, Zuniga E, Barnes SR, Prince J, Sagare M, Hsu C, Ladu MJ, Jacobs RE, Zlokovic BV. APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer’s mice via cyclophilin A independently of amyloid-β. Nat Aging. 2021;1:506–20.PubMedPubMedCentralCrossRef Montagne A, Nikolakopoulou AM, Huuskonen MT, Sagare AP, Lawson EJ, Lazic D, Rege SV, Grond A, Zuniga E, Barnes SR, Prince J, Sagare M, Hsu C, Ladu MJ, Jacobs RE, Zlokovic BV. APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer’s mice via cyclophilin A independently of amyloid-β. Nat Aging. 2021;1:506–20.PubMedPubMedCentralCrossRef